Rewind Therapeutics Appoints Dr. Irene Knuesel on Chief Scientific…
– Former Roche head of neuroimmunology strengthens Rewind’s expertise in neuroimmunology and neurodegeneration Leuven, Belgium, October 19, 2022 — Rewind Therapeuticsa company developing first-in-class treatments